RBPJ and rheumatoid arthritis: Building on the insights garnered from this epigenetic mechanism, we engineered progenitor cells with a modified DNA methylation pattern in the Rbpjk gene and achieved promising fracture nonunion treatment by applying local cell therapy in RA mice, which represents a promising therapeutic option for delayed fracture and fracture nonunion treatment in the clinic.